A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus produces hospital- and community-acquired infections, with methicillin-resistant S. aureus posing a serious public health threat. The golden carotenoid pigment of S. aureus , staphyloxanthin, promotes resistance to reactive oxygen species and host neutrophil-based killing, and early enzymatic steps in staphyloxanthin production resemble those for cholesterol biosynthesis. We determined the crystal structures of S. aureus dehydrosqualene synthase (CrtM) at 1.58 angstrom resolution, finding structural similarity to human squalene synthase (SQS). We screened nine SQS inhibitors and determined the structures of three, bound to CrtM. One, previously tested for cholesterol-lowering activity in humans, blocked staphyloxanthin biosynthesis in vitro (median inhibitory concentration ∼100 nM), resulting in colorless bacteria with increased susceptibility to killing by human blood and to innate immune clearance in a mouse infection model. This finding represents proof of principle for a virulence factor–based therapy against S. aureus .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To combat ROS, S. aureus uses a number of defensive molecules, including catalase (KatA), superoxide dismutases (SodA/M), and the golden pigment staphyloxanthin (36–44).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [37]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is important because the generation of reactive oxygen species (ROS) such as O2− and H2O2 by neutrophils is a crucial host defense mechanism against S. aureus (36, 37).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Liu, G. Y., Essex, A., Buchanan, J. T., Datta, V., Hoffman, H. M., Bastian, J. F., Fierer, J., & Nizet, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050846 · Cited by 752
Self-citationClauditz, A., Resch, A., Wieland, K.-P., Peschel, A., & Götz, F. (2006) · Infection and Immunity · doi:10.1128/iai.00204-06 · Cited by 509
Lyon, G. J., Mayville, P., Muir, T. W., & Novick, R. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13330 · Cited by 263
Crystal Structure of Human Squalene Synthase
Pandit, J., Danley, D. E., Schulte, G. K., Mazzalupo, S., Pauly, T. A., Hayward, C. M., Hamanaka, E. S., Thompson, J. F., & Harwood, H. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004132200 · Cited by 238
Bisphosphonates target multiple sites in both cis - and trans -prenyltransferases
Guo, R.-T., Cao, R., Liang, P.-H., Ko, T.-P., Chang, T.-H., Hudock, M. P., Jeng, W.-Y., Chen, C. K.-M., Zhang, Y., Song, Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702254104 · Cited by 184
Self-citationBacterial virulence as a target for antimicrobial chemotherapy
Alksne, L. E., & Projan, S. J. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00155-5 · Cited by 158
Antimicrobial Resistance: It's Not Just for Hospitals
Bancroft, E. A. (2007) · JAMA · doi:10.1001/jama.298.15.1803 · Cited by 141
Anchor Structure of Staphylococcal Surface Proteins
Ton-That, H., & Schneewind, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24316 · Cited by 140
Research works printed but not linked: 1
- National Research Council, in Treating Infectious Diseases in a Microbial World: Report of Two Workshops on Novel Antimicrobial Therapeutics (National Academies Press, Washington, DC, 2006), pp. 21–22.
Cited by
Items 201–300 of 505
Shaka, M., Arias-Rojas, A., Hrdina, A., Frahm, D., & Iatsenko, I. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010825 · Cited by 38
Gogisetti, G., Kanna, U., Sharma, V., Allaka, T. R., & Rao, T. B. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200681 · Cited by 34
Synthesis and biological activity of Citridone A and its derivatives
Fukuda, T., Shimoyama, K., Nagamitsu, T., & Tomoda, H. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.14 · Cited by 33
Hartmann, T., Baronian, G., Nippe, N., Voss, M., Schulthess, B., Wolz, C., Eisenbeis, J., Schmidt‐Hohagen, K., Gaupp, R., Sunderkötter, C. H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.584979 · Cited by 48
“Because both TCA cycle activity (17–22) and pigment production (16, 23, 24) affect virulence determinant synthesis and/or infectivity of S.”
Small-Molecule Potentiators for Conventional Antibiotics against Staphylococcus aureus
Vermote, A., & Calenbergh, S. V. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00084 · Cited by 40
Evolutionary investigations of the biosynthetic diversity in the skin microbiome using lsaBGC
Salamzade, R., Cheong, J. Z. A., Sandstrom, S., Swaney, M. H., Stubbendieck, R. M., Starr, N. L., Currie, C. R., Singh, A. M., & Kalan, L. (2023) · Microbial Genomics · doi:10.1099/mgen.0.000988 · Cited by 37
Repurposing libraries of eukaryotic protein kinase inhibitors for antibiotic discovery
Walsh, C. T., & Fischbach, M. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813405106 · Cited by 33
“Two target classes that might be worth particular attention are ion channels and prenyltransferases (9).”
BackgroundTargeting virulence factors as an antimicrobial approach: Pigment inhibitors
Ni, S., Li, B., Xu, Y., Mao, F., Li, X., Lan, L., Zhu, J., & Li, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21621 · Cited by 34
“On the basis of this finding, eight known SQS inhibitors were selected by Oldfield’s group to determine whether they were able to bind to CrtM.(85) According to the report, replacement of the phosphonate group of FPP with a sulfonate moiety resulted in four structural mimic compounds F IGURE 4 (A) Early application of…”
InfluentialShareef, M. A., Kanugala, S., Sayeed, I. B., Khan, I., Ganapathi, T., Akbar, S., Kumar, C. G., Kamal, Ä., & Babu, B. N. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.08.025 · Cited by 33
Lemire, B. D. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.04.005 · Cited by 31
Dunga, A. K., Allaka, T. R., Kethavarapu, Y., Nechipadappu, S. K., Pothana, P., Kishore, R., Kashanna, J., & Kishore, P. V. V. N. (2022) · Results in Chemistry · doi:10.1016/j.rechem.2022.100605 · Cited by 35
Heo, J., Kim, S. H., & Lee, P. C. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.00071-13 · Cited by 30
(±)-Tylopilusins, Diphenolic Metabolites from the Fruiting Bodies of Tylopilus eximius
Fukuda, T., Nagai, K., & Tomoda, H. (2012) · Journal of Natural Products · doi:10.1021/np300428r · Cited by 31
Li, B., Ni, S., Mao, F., Chen, F., Liu, Y., Wei, H., Chen, W., Zhu, J., Lan, L., & Li, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01300 · Cited by 29
Wang, Y., Di, H., Chen, F., Xu, Y., Xiao, Q., Wang, X., Wei, H., Lu, Y., Zhang, L., Zhu, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00122 · Cited by 28
Thomsen, I. P., & Liu, G. Y. (2018) · JCI Insight · doi:10.1172/jci.insight.98216 · Cited by 30
Self-citationNi, S., Wei, H., Li, B., Chen, F., Liu, Y., Chen, W., Xu, Y., Qiu, X., Li, X., Lu, Y., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00949 · Cited by 25
Potential antimicrobial agents from triazole-functionalized 2H-benzo[b][1,4]oxazin-3(4H)-ones
Bollu, R., Banu, S., Bantu, R., Reddy, A. G., Nagarapu, L., Sirisha, K., Kumar, C. G., Gunda, S. K., & Shaik, K. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.10.061 · Cited by 29
Discovery of Lipophilic Bisphosphonates That Target Bacterial Cell Wall and Quinone Biosynthesis
Malwal, S. R., Chen, L., Hicks, H., Qu, F., Liu, W., Shillo, A., Law, W. X., Zhang, J., Chandnani, N., Han, X., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01878 · Cited by 26
Self-citationQuantitative Map of β-Lactone-Induced Virulence Regulation
Krysiak, J. M., Stahl, M. M. S., Vomacka, J., Fetzer, C., Lakemeyer, M., Fux, A., & Sieber, S. A. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00705 · Cited by 26
Lauryl-poly-L-lysine: A New Antimicrobial Agent?
Vidal, L., Thuault, V., Mangas, A., Coveñas, R., Thienpont, A., & Geffard, M. (2014) · Journal of Amino Acids · doi:10.1155/2014/672367 · Cited by 27
“In the United States, in medical facilities and the general community, more deaths have been caused by methicillinresistant Staphylococcus aureus (MRSA) infections than by HIV/AIDS [2].”
BackgroundTerpene Cyclases and Prenyltransferases: Structures and Mechanisms of Action
Chen, C., Malwal, S. R., Han, X., Liu, W., Ma, L., Zhai, C., Dai, L., Huang, J.-W., Shillo, A., Desai, J., et al. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c04710 · Cited by 25
Self-citationWang, H., Hou, X., Shen, J., Wang, W., Ye, Y., Yu, J., & Xue, T. (2022) · LWT · doi:10.1016/j.lwt.2022.113515 · Cited by 25
Targeting the host–pathogen interface for treatment of Staphylococcus aureus infection
Park, B., & Liu, G. Y. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0297-1 · Cited by 29
Self-citationGraphiumins, new thiodiketopiperazines from the marine-derived fungus Graphium sp. OPMF00224
Fukuda, T., Shinkai, M., Sasaki, E., Nagai, K., Kurihara, Y., Kanamoto, A., & Tomoda, H. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.41 · Cited by 25
Tao, X., Zhang, Z., Zhang, X., Li, H., Sun, H., Mao, Z., & Xia, W. T. (2020) · CCS Chemistry · doi:10.31635/ccschem.020.202000219 · Cited by 26
Removing the Golden Coat of Staphylococcus aureus
Daum, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmcibr0803278 · Cited by 24
Manipulating virulence factor availability can have complex consequences for infections
Weigert, M., Ross‐Gillespie, A., Leinweber, A., Pessi, G., Brown, S. P., & Kümmerli, R. (2016) · Evolutionary Applications · doi:10.1111/eva.12431 · Cited by 27
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies
Hsieh, R. C., Liu, R., Burgin, D. J., & Otto, M. J. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2242585 · Cited by 26
Small molecule natural products in human nasal/oral microbiota
Barber, C. C., & Zhang, W. (2021) · Journal of Industrial Microbiology & Biotechnology · doi:10.1093/jimb/kuab010 · Cited by 26
“, 2016), leading to investigation of several virulence-attenuating candidates (Liu et al., 2008; Lee et al., 2013; Leejae et al., 2013; Ribeiro et al., 2020; Song, Lin, et al., 2009; Song, Liu, et al., 2009).”
BackgroundGlyceryl trinitrate blocks staphyloxanthin and biofilm formation in Staphylococcus aureus
Abbas, H. A., Elsherbini, A. M., & Shaldam, M. A. (2019) · African Health Sciences · doi:10.4314/ahs.v19i1.10 · Cited by 25
Head-to-Head Prenyl Tranferases: Anti-Infective Drug Targets
Lin, F., Liu, Y.-L., Li, K., Cao, R., Zhu, W., Axelson, J. C., Pang, R., & Oldfield, E. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300208p · Cited by 23
Self-citationEnantioselective Inhibition of Squalene Synthase by Aziridine Analogues of Presqualene Diphosphate
Koohang, A., Bailey, J. L., Coates, R. M., Erickson, H. K., Owen, D. J., & Poulter, C. D. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo100718z · Cited by 23
Baddam, S. R., Avula, M. K., Akula, R., Battula, V. R., Kalagara, S., Buchikonda, R., Ganta, S., Srinivasadesikan, V., & Allaka, T. R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27773 · Cited by 22
Interactions of staphyloxanthin and enterobactin with myeloperoxidase and reactive chlorine species
Coker, M. S. A., Forbes, L. V., Plowman-Holmes, M., Murdoch, D. R., Winterbourn, C. C., & Kettle, A. J. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.03.039 · Cited by 24
El-Ganiny, A. M., Gad, A. I., El-Sayed, M. A., Shaldam, M. A., & Abbas, H. A. (2021) · Brazilian Journal of Microbiology · doi:10.1007/s42770-021-00655-4 · Cited by 21
“The crystal structure of the four studied proteins; hemolysin (7AHL [45]), sortase enzyme (2KID [46]), AgrA LytTR (3BS1 [47]), and dehydrosqualene synthase (2ZCQ [48]) were retrieved from the Protein Data Bank.”
MethodBioorganic Chemistry. A Natural Reunion of the Physical and Life Sciences
Poulter, C. D. (2009) · The Journal of Organic Chemistry · doi:10.1021/jo900183c · Cited by 22
Nathan, C. (2008) · Science · doi:10.1126/science.1167452 · Cited by 21
Dong, G., Liu, Y., Wu, Y., Tu, J., Chen, S., Liu, N., & Sheng, C. (2018) · Chemical Communications · doi:10.1039/c8cc07810f · Cited by 23
Cvijetić, I., Verbić, T. Ž., de Resende, P. E., Stapleton, P. D., Gibbons, S., Juranić, I. O., Drakulić, B. J., & Zloh, M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.045 · Cited by 21
Hamdi, A., Horchani, M., Jannet, H. B., Snoussi, M., Noumi, E., Bouali, N., Kadri, A., Polito, F., Feo, V. D., & Edziri, H. (2023) · Pharmaceuticals · doi:10.3390/ph16121669 · Cited by 20
“…and “the crystal structure of the C (30) carotenoid dehydrosqualene synthase from S. aureus complexed with bisphosphonate BPH-652” (PDB: 2ZCQ) [55] with grid box parameters of 30 (x-dimension) × 30 (y-dimension) × 30 (z-dimension) Å and x, y and z values of 15.285, 54.913 and 41.662,…”
BackgroundInfluentialMorikawa, K., Ohniwa, R. L., Ohta, T., Tanaka, Y., Takeyasu, K., & Msadek, T. (2010) · Microbes and Environments · doi:10.1264/jsme2.me10116 · Cited by 22
Farnesyl Diphosphate Synthase Inhibitors With Unique Ligand-Binding Geometries
Liu, Y.-L., Cao, R., Wang, Y., & Oldfield, E. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500528x · Cited by 20
Self-citationCharacterization and engineering of a carotenoid biosynthesis operon from Bacillus megaterium
Hartz, P., Milhim, M., Trenkamp, S., Bernhardt, R., & Hannemann, F. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.07.017 · Cited by 20
HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis
Zhang, Y., Lin, F., Li, K., Zhu, W., Liu, Y.-L., Cao, R., Pang, R., Lee, E., Axelson, J. C., Hensler, M. E., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300038t · Cited by 21
Self-citationYue, C., Yuan, Z., Xu, G., Guan, X., Wei, B., Yao, H., Yang, C., & Zhang, T. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01615 · Cited by 19
Zika virus non-structural protein 4B interacts with DHCR7 to facilitate viral infection
Chen, W., Li, Y., Yu, X., Wang, Z., Wang, W., Rao, M., Li, Y., Luo, Z., Zhang, Q., Liu, J., et al. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.09.009 · Cited by 18
Taj, Z., & Chattopadhyay, I. (2024) · Springer eBooks · doi:10.1007/978-981-99-8799-3_8 · Cited by 17
Dual Dehydrosqualene/Squalene Synthase Inhibitors: Leads for Innate Immune System‐Based Therapeutics
Lin, F., Zhang, Y., Hensler, M. E., Liu, Y., Chow, O. A., Zhu, W., Wang, K., Pang, R., Thienphrapa, W., Nizet, V., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201100589 · Cited by 19
Self-citationRapid Analysis of Pharmacology for Infectious Diseases
Hopkins, A. L., Bickerton, G. R., Carruthers, I. M., Boyer, S., Rubin, H. N., & Overington, J. P. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795429130 · Cited by 22
New Approaches to Drug Discovery for Combating MRSA
Tomoda, H. (2016) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c15-00743 · Cited by 25
Chemical Intervention on Staphylococcus aureus Virulence
Zhou, L., & Yang, C. (2018) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201800470 · Cited by 20
Aspergillus flavus squalene synthase as an antifungal target: Expression, activity, and inhibition
Song, J., Shang, N., Baig, N., Yao, J., Shin, C. J., Kim, B. K., Li, Q., Malwal, S. R., Oldfield, E., Feng, X., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.070 · Cited by 20
Self-citationYe, X., Huang, Y. F., Zhou, C., Liu, X., Zhao, W., Zhao, X., Xie, X., Wang, L., Bai, Z., Zhou, C., et al. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126909 · Cited by 20
Su, J.-C., Huang, Y., Chen, C., Chiu, H., & Shiau, C. (2017) · Molecules · doi:10.3390/molecules23010027 · Cited by 19
Discovery of New Anti-MRSA Agents Based on Phenoxyethanol and Its Mechanism
Xie, J., Wang, L., Zhang, X., Li, Y., Liao, X. D., Yang, C., & Tang, R. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00365 · Cited by 18
Metwaly, A. M., Saleh, M. M., Alsfouk, B. A. A., Ibrahim, I. M., Abd‐Elraouf, M., Elkaeed, E. B., & Eissa, I. H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24075 · Cited by 18
“In brief, the crystal structure of the CrtM protein with B70 was processed by removing crystallographic water molecules except H 2 O482, H 2 O515, and H 2 O582 which were reported to form water-mediated hydrogen bonds as seen in the reported binding mode of the co-crystallized ligand [30].”
BackgroundBatool, N., Shamim, A., Chaurasia, A. K., & Kim, K. K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.613800 · Cited by 20
Na-Phatthalung, P., Chusri, S., Suanyuk, N., & Voravuthikunchai, S. P. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000453 · Cited by 18
“aureus to innate immune clearance in vivo [37].”
BackgroundTan, L., & Bajorath, J. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00829.x · Cited by 19
“For SS, the structure of an enzyme-inhibitor complex has been determined (26) and, recently, also for the distantly related bacterial dehydrosqualene synthase (27).”
BackgroundInnovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens
Lorente-Torres, B., Llano-Verdeja, J., Castañera, P., Ferrero, H. Á., Fernández-Martínez, S., Javadimarand, F., Mateos, L. M., Letek, M., & Mourenza, Á. (2024) · Antibiotics · doi:10.3390/antibiotics13090834 · Cited by 24
“Interest-ingly, BPH-652, a cholesterol-lowering agent, binds to the dehydrosqualene synthase of S. aureus , reducing staphylotoxin and restoring the toxic effect of ROS against S. aureus [34].”
BackgroundShi, J., Chen, C., Kong, P., Yu, F., Lv, Q., Wang, Z., & Liu, Y. (2025) · Advanced Science · doi:10.1002/advs.202416260 · Cited by 19
Construction of a Nonnatural C 60 Carotenoid Biosynthetic Pathway
Li, L., Furubayashi, M., Hosoi, T., Seki, T., Otani, Y., Kawai‐Noma, S., Saito, K., & Umeno, D. (2019) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00385 · Cited by 18
He, W., Tashiro, S., & Shionoya, M. (2022) · Chemical Science · doi:10.1039/d2sc01561g · Cited by 17
Inhibitors of Sterol Biosynthesis as Staphylococcus aureus Antibiotics
Walsh, C. T., & Fischbach, M. A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801801 · Cited by 18
Nikolić, D., Dimitrijevic-Sreckovic, V. S., Ranin, L. T., Stojanovic, M. M., Ilic, I., Gostiljac, D., & Soldatovic, I. A. (2022) · Medicine · doi:10.1097/md.0000000000031291 · Cited by 17
“Cholesterol-lowering therapy may reduce the pathogenicity of Staphylococcus, due to similarities in the pathways for staphyloxanthin and human cholesterol biosynthesis.[40] These results are obtained from studies on mice and we don’t know how this will reflect in humans.”
BackgroundEugenol targeting CrtM inhibits the biosynthesis of staphyloxanthin in Staphylococcus aureus
Chang, J., Chen, B., Du, Z., Zhao, B., Li, J., Li, Z., Kannappan, A., Shi, T., Wei, D., & Shi, C. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250115 · Cited by 16
Impact of Deficiencies in Branched-Chain Fatty Acids and Staphyloxanthin in Staphylococcus aureus
Braungardt, H., & Singh, V. K. (2019) · BioMed Research International · doi:10.1155/2019/2603435 · Cited by 18
“aureus cells to neutrophil killing [13, 30].”
Ohtake, K., Saito, N., Shibuya, S., Kobayashi, W., Amano, R., Hirai, T., Sasaki, S., Nakano, C., & Hoshino, T. (2014) · FEBS Journal · doi:10.1111/febs.13090 · Cited by 16
Antibacterial Activity of Paroxetine Against Staphylococcus Aureus and Possible Mechanisms of Action
Cabral, V. P. D. F., Rodrigues, D. S., Barbosa, A. D., Moreira, L. E. A., Sá, L. G. D. A. V., da Silva, C. R., Neto, J. B., Silva, J., Marinho, E. S., dos Santos, H. S., et al. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0232 · Cited by 17
Ni, L., Shen, R., Luo, H., Li, X., Zhang, X., Huang, L., Deng, Y., Liao, X., Wu, Y., Duan, C., et al. (2024) · Virulence · doi:10.1080/21505594.2024.2352476 · Cited by 16
“As an important virulence factor, staphyloxanthin can impair neutrophil killing and protect bacteria against the host innate immune system [43].”
BackgroundFlotillin-mediated stabilization of unfolded proteins in bacterial membrane microdomains
Ukleja, M., Kricks, L., Torrens, G., Peschiera, I., Lopes, I. R., Krupka, M., García‐Fernández, J., Melero, R., del Campo, R., Eulálio, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49951-1 · Cited by 19
“As we showed that FMM are necessary to prevent PBP2a from unfolding during oxidative stress, MEV inhibitors may additionally cause PBP2a to unfold in these MRSA isolates that show higher levels of β -lactam resistance than USA300.”
InfluentialSynthesis, characterization, and antibacterial activity of novel pyrazole derivatives
Vashisht, K., Sethi, P., Ramasamy, S. K., Bansal, A., Dar, M. O., Singh, M. K., Alkhanjaf, A. A. M., Ibrahim, A. A., Umar, A., Kumar, R., et al. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141706 · Cited by 15
Synchrotron Radiation Facilities in Taiwan
Liang, K. S., Luo, G.-H., Chen, J., Huang, D. J., Hwang, C.-S., Wang, C., & Chen, C. T. (2009) · Synchrotron Radiation News · doi:10.1080/08940880903256783 · Cited by 15
“The structure of a key enzyme in synthesizing carotenoid pigment in golden yellow staphylococcus solved by Andrew Wang and collaborators using the NSRRC facility may provide important information toward designing new cholesterol-lowering medicines in the future [ 7 ].”
BackgroundNi, S., Li, B., Chen, F., Wei, H., Mao, F., Liu, Y., Xu, Y., Qiu, X., Li, X., Liu, W., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00501 · Cited by 16
Signaling Natural Products from Human Pathogenic Bacteria
Hu, Z., & Zhang, W. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00286 · Cited by 16
Potent, specific MEPicides for treatment of zoonotic staphylococci
Edwards, R. L., Heueck, I., Lee, S. G., Shah, I. T., Miller, J. J., Jezewski, A. J., Mikati, M. O., Wang, X., Brothers, R. C., Heidel, K. M., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1007806 · Cited by 17
Hafeez, S., Rasool, Z., Hafeez, S., Paracha, R. Z., Iqbal, M., Khan, D., & Adnan, F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39829 · Cited by 14
“Due to the characteristic resistance of UPEC to phagocytes such as neutrophils and monocytes, a survival assay was used to investigate the effects of ILs on UPEC survival in the presence of human whole blood [34,35].”
Cholesterol sensing by the SCAP–FAM134B complex regulates ER-phagy and STING innate immunity
Li, B., Zhou, D., Wang, X., Jiang, X. M., Sang, Y., Dai, Y., Yu, Y., Zhang, Y., Chen, C., Li, S., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01766-y · Cited by 18
Brought to you courtesy of the red, white, and blue–pigments of nontuberculous mycobacteria
Tran, T., Dawrs, S. N., Norton, G. J., Virdi, R., & Honda, J. R. (2020) · AIMS Microbiology · doi:10.3934/microbiol.2020026 · Cited by 14
Peptidomimetics as Potential Anti-Virulence Drugs Against Resistant Bacterial Pathogens
Martínez, O. F., Duque, H. M., & Franco, O. L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.831037 · Cited by 14
Malwal, S. R., Shang, N., Liu, W., Li, X., Zhang, L., Chen, C., Guo, R., & Oldfield, E. (2022) · ACS Omega · doi:10.1021/acsomega.2c01924 · Cited by 14
Self-citationRashid, H. U., Khan, S., Irum, Khan, A. U., Ahmad, N., Shah, T., & Khan, K. (2024) · Royal Society Open Science · doi:10.1098/rsos.240410 · Cited by 14
“By forming such interactions in the vicinity of the active site, compound 3q can have the ability to hinder the normal function of the CrtM protein of S. aureus [47].”
BackgroundChen, Y., Li, W., Wang, L., Wang, B., & Suo, J. (2024) · Applied and Environmental Microbiology · doi:10.1128/aem.01804-24 · Cited by 14
Desouky, S. E., El-Gamal, M. S., Mohammed, A. F., & Abu‐Elghait, M. (2014) · Cited by 19
Catalan‐Moreno, A., Caballero, C. J., Irurzun, N., Cuesta, S., López‐Sagaseta, J., & Toledo‐Arana, A. (2019) · Molecular Microbiology · doi:10.1111/mmi.14446 · Cited by 14
“Therefore, STX has been proposed as a potential target when fighting MRSA infections (Liu et al., 2008).”
BackgroundLiu, K., Abouelhassan, Y., Zhang, Y., Jin, S., & Huigens, R. W. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00206 · Cited by 12
Differential survival of Staphylococcal species in macrophages
Bayer, J., Becker, J., Liu, X., Gritsch, L., Daiber, E., Korn, N., Oesterhelt, F., Fraunholz, M. J., Weber, A. N. R., & Wolz, C. (2023) · Molecular Microbiology · doi:10.1111/mmi.15184 · Cited by 14
Nachammai, K. T., Prabu, D., Kasilingam, H., Sangavi, P., Arumugam, V. R., & Kulanthaivel, L. (2024) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2024.103442 · Cited by 13
Directed evolution of squalene synthase for dehydrosqualene biosynthesis
Furubayashi, M., Li, L., Katabami, A., Saito, K., & Umeno, D. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.07.028 · Cited by 15
Büren, C., Lögters, T. T., Oezel, L., Rommelfanger, G., Scholz, A. O., Windolf, J., & Windolf, C. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191594 · Cited by 13
Shen, Y., Zhang, L., Yang, M., Shi, T., Li, Y., Li, L., Yu, Y., Deng, H., Lin, H., & Zhou, Y. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00756 · Cited by 13
The enzyme activity of sortase A is regulated by phosphorylation in Staphylococcus aureus
Chen, F., Di, H., Wang, Y., Peng, C., Chen, R., Pan, H., Yang, C., Liang, H., & Lan, L. (2023) · Virulence · doi:10.1080/21505594.2023.2171641 · Cited by 14
“aureus virulence [2–5] and may include the inhibition of pathways such carotenoid biosynthetic pathway [6,7], accessory gene regulator (agr) [8–10], and sortase enzymes that anchor surface proteins to the cell wall [11–18].”
BackgroundSchelz, Z., Muddather, H. F., & Zupkó, I. (2023) · Antibiotics · doi:10.3390/antibiotics12091468 · Cited by 14
“HMG-CoA reductase inhibitors can inhibit the activity of bacterial HMG-CoA reductase and thus interfere with isoprenoid biosynthesis, which may contribute to their antibacterial effects [69].”
BackgroundAttenuation of antimicrobial activity by the human steroid hormones
Plotkin, B. J., & Konakieva, M. I. (2017) · Steroids · doi:10.1016/j.steroids.2017.09.007 · Cited by 13
“aureus can synthesize cholesterol, indicating the presence of a mevalonate-like pathway, the pathway which may be affected by statins [67].”
BackgroundCueno, M. E., & Imai, K. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.03.010 · Cited by 14
Measurement of Staphylococcus aureus Pigmentation by Methanol Extraction
Sullivan, L. E., & Rice, K. C. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1550-8_1 · Cited by 14
Identification of a New Antimicrobial Agent against Bovine Mastitis-Causing Staphylococcus aureus
Shin, M., Mun, D., Choi, H. J., Kim, S., Payne, S. M., & Kim, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02738 · Cited by 13
Epithelial Cell Gene Expression Induced by IntracellularStaphylococcus aureus
Li, X., Fusco, W. G., Seo, K. S., Bayles, K. W., Mosley, E. E., McGuire, M. A., & Bohach, G. A. (2009) · International Journal of Microbiology · doi:10.1155/2009/753278 · Cited by 16
“aureus pigment, staphyloxanthin, is synthesized with the same substrates used for cholesterol biosynthesis by host cells [72].”
BackgroundMicroorganisms Found in Fast and Traditional Fast Food
Easa, S. M. H. (2010) · Cited by 12
Metadata
- Authors
- Liu, C.-I., Liu, G. Y., Song, Y., Yin, F., Hensler, M. E., Jeng, W.-Y., Nizet, V., Wang, A. H.-J., & Oldfield, E.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Liu, Chia-I
- Liu, George Y.
- Song, Yongcheng
- Nizet, Victor
- Wang, Andrew H.-J.
- Oldfield, Eric
- Venue
- Science
- Published
- 2008-03-07
- Volume
- 319
- Issue
- 5868
- Pages
- 1391-1394
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2747771
- OpenAlex
- W1986930831
- Cited by
- 490
- References
- 16
- Citations by year
- 2026: 16 · 2025: 28 · 2024: 34 · 2023: 26 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 31 · 2018: 28 · 2017: 40 · 2016: 23 · 2015: 17 · 2014: 32 · 2013: 26 · 2012: 33
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM065307, GM073216, R01GM073216, GM65307)
- National Institute of Allergy and Infectious Diseases (AI07482)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 051796, R01HD051796)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Metabolism and Applications
- Keywords
- Staphylococcus aureus, cholesterol synthesis inhibition, CRTM, squalene synthase inhibitors, methicillin-resistant Staphylococcus aureus, bacterial virulence, reactive oxygen species resistance, crystal structure
- MeSH terms
- Amino Acid Sequence, Animals, Anti-Bacterial Agents, Bacterial Proteins, Cell Line, Cholesterol, Enzyme Inhibitors, Humans, Molecular Sequence Data, Organothiophosphorus Compounds, Polyisoprenyl Phosphates, Sesquiterpenes, Farnesyl-Diphosphate Farnesyltransferase, Staphylococcal Infections, Staphylococcus aureus, Virulence, Protein Structure, Secondary, Crystallography, X-Ray, Xanthophylls, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.